Site comparison
Amavita Research vs. an academic medical center: which clinical trial site fits your study?
This page is the broader version of the academic medical center comparison: a structural look at how an independent specialist site differs from an academic medical center across decision speed, contracting, IRB turnaround, and sponsor-team responsiveness.
Academic medical centers anchor the scientific infrastructure of clinical research. Faculty PIs, fellowship programs, NIH funding, and translational cores all live there. For investigator-initiated programs and novel-endpoint science, an AMC is typically the right home.
The structural cost of the AMC model is governance overhead. Faculty time is divided across clinical care, teaching, and research. Contracting moves through the institutional Office of Research, often with multiple committee reviews. IRB cycles run on institutional schedules. Sponsor-facing decisions are distributed across the Office of Research, the relevant department, and the study team.
An independent specialist site is structurally different. There is no Office of Research between the sponsor and the PI. Contracting is owned by the site directly. IRB submission is managed by the site team without institutional committee dependencies. The sponsor-facing decision-maker is the same person who executes the protocol.
The result is measurable in startup time. Amavita Research targets contract turnaround in days, not quarters, and sub-two-week IRB submission. Sponsor questions are answered the same business day by the BD owner (Nereisy Alonso, Sr CRC), not routed through three institutional layers.
Sponsor-team responsiveness compounds this. At an independent specialist site, the PI, lead CRC, regulatory specialist, and BD contact work in the same building and report into the same operational chain. At an AMC, those roles often span departments and report through different chains of authority.
The trade-off sponsors face is genuine. AMCs deliver academic infrastructure, faculty-led PI bandwidth, and institutional credibility. Independent specialist sites deliver decision speed, focused operational depth, and direct sponsor-team responsiveness. Many sponsor programs use both - AMCs for the academic component, independent specialist sites for execution-driven enrollment.
Amavita Research is the independent specialist option for cardiovascular trials in South Florida.
Side-by-side: operating model
Educational summary. We describe the typical operating model comparison model and do not make claims about any specific institution's current operations.
| Dimension | Amavita Research | Academic Medical Center (general) (typical) |
|---|---|---|
| Governance model | Site-owned, single chain of authority | Institutional, multi-committee |
| Decision speed | Same business day | Days to weeks per layer |
| Contracting turnaround | Days, not quarters; sub-2-week IRB turnaround | Office of Research cycles |
| IRB turnaround | Sub-two-week submission | Institutional IRB schedule |
| Sponsor-team responsiveness | Single BD owner, co-located team | Distributed across departments |
| Best fit | Sponsor-led execution, timeline-sensitive | Academic-led science, novel endpoints |
| AI-search readiness | llms.txt + Wikidata + MedicalStudy/JobPosting/FAQ schema | Institutional website |
Frequently asked questions
Why is decision speed structurally different at an independent site?
There are fewer organizational layers between the sponsor question and the person empowered to answer it. The PI, BD contact, and operations team are co-located and report into the same chain.
How meaningful is contracting speed in a Phase 2-3 program?
Very. Each week of contracting delay typically maps to a week of enrollment delay, which compounds across multi-site programs. Independent sites can materially reduce this risk.
Should sponsors avoid AMCs?
No. AMCs are essential for academic-led science, novel endpoints, and programs that depend on translational infrastructure. The question is matching the site model to the protocol.
Can sponsors combine independent sites and AMCs in one program?
Yes, and many do. Independent specialist sites typically anchor enrollment cadence; AMCs anchor academic credibility and translational depth.
Where does Amavita fit on this axis?
Amavita is the independent cardiovascular specialist option in South Florida - structured for decision speed, focused depth, and direct sponsor-team responsiveness.
Next step
Schedule a 20-minute capabilities call
One contact. Same-business-day response. Feasibility, budget, contracts, and monitor access all from a single owner.